Phloracetophenone (1-(2,4,6-Trihydroxyphenyl)ethanone) is a research compound studied for its potential anti-obesity and lipid-lowering properties. Its mechanism is linked to pancreatic lipase inhibition, which can reduce dietary fat absorption, as investigated in both in vitro enzymatic assays and in vivo metabolic studies.